GlassScriptPhysician profile
Neely Wade
NPI 1023032695
$750.68
in general payments reported to CMS, 2019-2025
16 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.48 · 2020: $31.70 · 2021: $12.78 · 2022: $96.72 · 2023: $30.53 · 2024: $290 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $191.57 | 2021-2025 | Veozah |
| Sage Therapeutics, LLC | $86.79 | 2019-2025 | Zurzuvae |
| Amgen INC. | $74.14 | 2024-2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $63.15 | 2024-2025 | Aptima, Thinprep 2000 Processor, Omni Hysteroscope |
| Aspira Women'S Health INC | $62.42 | 2022-2024 | Ova1 |
| Merck Sharp & Dohme LLC | $57.77 | 2023-2025 | Gardasil 9, Gardasil |
| Organon LLC | $43.23 | 2023-2025 | Nexplanon |
| Abbvie INC. | $29.11 | 2024 | |
| Minerva Surgical, INC | $28.36 | 2019-2024 | |
| Coloplast Corp | $20.23 | 2022 | |
| Baxter Healthcare | $19.42 | 2020 | |
| Exeltis, USA INC. | $18.26 | 2025 | Slynd |
| Convatec INC. | $15.59 | 2019 | |
| Gynesonics, INC. | $14.19 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Radius Health, INC. | $14.17 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neely Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.